Published Jun 14, 2019

#234 Dexcom CEO Kevin Sayer Returns

Dexcom CEO Kevin Sayer returns to reveal exciting advancements in diabetes management, discussing improved supply chains, global expansion, and cutting-edge innovations, including the G6 and G7 models and Apple Watch integration.
Episode Highlights
Juicebox Podcast: Type 1 Diabetes logo

Popular Clips

Questions from this episode

Episode Highlights

  • Accessibility

    Dexcom is actively working to improve the accessibility of its products through innovative strategies. acknowledges the stress patients face due to supply delays and insurance constraints, and he expresses a desire to make the process easier 1. He mentions exploring subscription models and enhancing retail partnerships to ensure consistent access to Dexcom products.

    We need business models where we're all more accountable. And where Dexcom has to be more accountable, is our products have to be more reliable.

    ---

    Additionally, Dexcom is restructuring its retail strategy to prevent financial losses and improve patient experience, with plans to integrate with major pharmacies like Walgreens and CVS 2.

       

    User Experience

    Enhancing the user experience is a key focus for Dexcom, with emphasizing the transformative impact of their products on diabetes management. shares personal insights, highlighting how Dexcom's data-driven approach has significantly improved his daughter's diabetes management 3. The company is committed to making diabetes management easier through technological advancements and patient feedback.

    Everything gets better when you can see the data that comes back from the Dexcom G Six.

    ---

    Sayer also discusses future innovations, such as integrated pens and decision support systems, aimed at reducing the burden on patients and caregivers 4.

Related Episodes